TACLONEX OINTMENT Rx
Generic Name and Formulations:
Calcipotriene (as hydrate) 0.005% + betamethasone dipropionate 0.064%.
LEO Pharma Inc.
Indications for TACLONEX OINTMENT:
Apply to affected areas once daily for up to 4 weeks. 12–17yrs: max 60g/wk. ≥18yrs: max 100g/wk. Limit treatment area to 30% body surface area. Do not occlude.
Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, or irritation occurs. Do not use on face, axillae, or groin, or if atrophy is present at treatment site. Avoid eyes, sun, UV light (eg, phototherapy). Treat infection if present. Allergic contact dermatitis. Pregnancy (Cat.C). Nursing mothers.
Systemic absorption potentiated by other corticosteroids.
Vit. D3 derivative + topical steroid.
Oint: pruritus, scaly rash. Susp: folliculitis, burning sensation of skin.
Oint—60g, 100g; Susp—60g, 2x60g